Ignite Creation Date:
2024-05-05 @ 11:07 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004854
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
2000-03-08
Brief Title:
The Safety and Efficacy of Adjunct Carvedilol in Children With Moderate Heart Failure
Sponsor:
National Center for Research Resources NCRR
Organization:
National Center for Research Resources NCRR
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2003-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We would like to see if using Carvedilol in adjunct with Ace inhibitors will increase ejection fraction of the heart under echo All interpretation of data will be sent to Boston Childrens Hospital to be reviewed which is the primary research center in this study There are 5 hospitals participating in this study The population targeted are children with moderate heart failure and must be on Ace inhibitors at the time of enrollment Our outcome after placing them on Carvedilol is to change their ejection fraction on echo The patients will be seen every 1-2 weeks while we will titrate their medication to a maintenance dose Secondary outcome is to increase quality of life exercise tolerance and decrease their symptom scores as noted on their questionnaires
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| M01RR000036 | NIH | None | httpsreporternihgovquickSearchM01RR000036 |